Revelation Biosciences (REVB) vs Silo Pharma (SILO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Revelation Biosciences is the larger company by market cap ($3.1 million vs $3.0 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | REVB | SILO |
|---|---|---|
| Share price | $0.7739 | $1.45 |
| Market cap | $3.08M | $2.98M |
| 1-day change | -6.55% | +0.69% |
| P/E ratio (TTM) | 0.17 | — |
| EPS (TTM) | $4.60 | $-4.26 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.24 | $10.44 |
| 52-week low | $0.75 | $1.30 |
| Distance from 52-week high | -87.60% | -86.11% |
| Average volume | 39.03K | 114.43K |
| Shares outstanding | 3.98M | 2.05M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
REVB vs SILO FAQ
Which is bigger, Revelation Biosciences or Silo Pharma?
Revelation Biosciences (REVB) is larger, with a market capitalization of $3.08M compared with $2.98M for Silo Pharma (SILO).
Are Revelation Biosciences and Silo Pharma in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.